Breadcrumbs Home Investors Press Releases Press Releases Press Releases Regulatory Press Releases More Press Releases Data Year2025202420232022202120202019201820172016201520142013201220112010 2020-03-27 08:30Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)Read more 2020-03-23 21:00Moberg Pharma enters financing agreement of up to SEK 216 million for further investments in MOB-015Read more 2020-03-23 08:00All patients in the European MOB-015 Phase 3 study have completed their last visitRead more 2020-02-11 08:00Moberg Pharma AB Interim report October - December 2019Read more 2020-02-04 08:00Moberg Pharma's Interim report to be published on February 11 - Invitation to teleconferenceRead more 2020-01-22 08:00Expert evaluation clarifies Phase 3 results and provides strong support for MOB-015Read more Pagination First page Previous page … Page 23 Page 24 Page 25 Page 26 Current page 27 Page 28 Page 29 Page 30 Page 31 … Next page Last page Press Releases Data Year2025202420232022202120202019201820172016201520142013201220112010 2019-02-11 18:00Moberg Pharma and Bayer sign exclusive license agreement for MOB-015 in EuropeRead more 2019-02-05 08:30Moberg Pharma's Year-end report to be published on February 12 - Invitation to teleconferenceRead more 2019-01-08 08:30Moberg Pharma appoints members to the Management teamRead more 2018-11-23 08:30Patent granted for MOB-015 in ChinaRead more 2018-11-08 08:30Moberg Pharma's nomination committee appointedRead more 2018-11-06 08:00Moberg Pharma AB Interim report January - September 2018Read more Pagination First page Previous page … Page 23 Page 24 Page 25 Page 26 Current page 27 Page 28 Page 29 Page 30 Page 31 … Next page Last page
